News

Gambit Ventures targets $10 mln for sophomore fund

Gambit Ventures is seeking to raise $10 million for its second fund, according to an SEC filing. The early-stage venture firm invests in companies in the New York City area.

Babel Health reels in $5 mln Series A

Babel Health, a provider of risk adjustment software and services to health plans, has raised $5 million in Series A funding. The investors included Draper Triangle Ventures.

NFX targets $275 mln for sophomore fund

NFX is seeking to raise $275 million for its second fund, according to an SEC filing. The San Francisco-based venture firm makes seed and Series A investments.

Sirnaomics nabs $47 mln

Gaithersburg, Maryland-based Sirnaomics Inc, a biopharmaceutical company focused on RNAi therapeutics against cancer and fibrotic diseases, has raised $47 million in funding. The investors included CR-CP Life Sciences Fund, Rich Yield Capital, Rolling Boulder Investment and Legend Sky Investment.

Symic Bio grabs $11 mln

Emeryville, California-based Symic Bio, a biopharmaceutical company, has raised $11 million. Cell Innovation Partners led the round.

BostonGene rakes in $50 mln Series A

BostonGene, a biomedical software provider, has raised $50 million in Series A funding. The investor was NEC Corporation.

Fund Performance: New Mexico ERB portfolio, 2013 to 2017

Clear Ventures partners discuss fund size, adding a partner and carving out seed deals

Mary Meeker’s Bond Capital attracts $1.25 bln for maiden fund: reports

Mary Meeker’s Bond Capital has confirmed a target of $1.25 billion for its maiden venture-capital fund, and, according to media reports, attracted commitments for the capital.

Rethink Education sets $150 mln target for third fund

Rethink Education is seeking to raise $150 million for its third fund, according to an SEC filing. The White Plains, New York-based venture firm invests in educational tech startups.